Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (trading symbol: NAOV) on April 19, 2023. The filing addresses corporate governance matters regarding the scheduling of the 2023 Annual Meeting of Stockholders and the deadlines for shareholder proposals and director nominations. Note: The input metadata references "Envue Medical, Inc.," but the filing text explicitly identifies the registrant as NanoVibronix, Inc.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance notifications and contains no financial performance data.
Material Changes
The primary material change reported is the rescheduling of the 2023 Annual Meeting of Stockholders. The Board of Directors determined the meeting will be held virtually on June 21, 2023. This date represents a change of more than 30 days from the anniversary of the 2022 Annual Meeting, triggering specific disclosure requirements for shareholder proposals.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on business operations. The document outlines procedural requirements and deadlines for shareholders:
- Record Date: Stockholders of record as of the close of business on April 28, 2023, are entitled to vote.
- Proposal Deadline: Proposals for inclusion in proxy materials under Rule 14a-8 must be received by the Company Secretary by the close of business on April 29, 2023.
- Nomination Deadline: Written notice for business proposals outside Rule 14a-8 or director nominations must also be received by the close of business on April 29, 2023.
- Universal Proxy Rules: Stockholders intending to solicit proxies for director nominees other than the company's nominees must provide notice by April 29, 2023.
Key Facts for Investor Verification
- Verify the correct registrant name is NanoVibronix, Inc., not Envue Medical, Inc.
- Confirm the 2023 Annual Meeting date is June 21, 2023, and the format is virtual.
- Note the strict deadline of April 29, 2023, for submitting shareholder proposals or director nominations.
- Check the record date of April 28, 2023, to determine voting eligibility.